Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 64.50M | £ 16.80M | £ 56.00M | £ 30.00M | £ 36.50M |
Total Assets | £ 346.90M | £ 428.20M | £ 276.70M | £ 242.80M | £ 262.10M |
Total Debt | £ 3.90M | £ 4.20M | £ 2.90M | £ 4.00M | £ 4.20M |
Net Debt | £ -60.60M | £ -12.60M | £ -53.10M | £ -26.00M | £ -32.30M |
Total Liabilities | £ 190.10M | £ 280.60M | £ 126.80M | £ 106.70M | £ 109.70M |
Stockholders Equity | £ 156.80M | £ 147.60M | £ 149.90M | £ 136.10M | £ 152.40M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |